Viewing Study NCT01933334


Ignite Creation Date: 2025-12-25 @ 2:34 AM
Ignite Modification Date: 2026-05-15 @ 4:24 PM
Study NCT ID: NCT01933334
Status: COMPLETED
Last Update Posted: 2016-08-04
First Post: 2013-08-23
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: Safety and Tolerability of Pirfenidone in Participants With Systemic Sclerosis-Related Interstitial Lung Disease (SSc-ILD) (LOTUSS)
Sponsor: Genentech, Inc.
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Systemic Sclerosis View
Keywords:

Keywords

Keyword Brief Keyword Text View
None pirfenidone View
None SSc-ILD View
None scleroderma View
None systemic sclerosis View
None interstitial lung disease View